moderna inc. - MRNA

Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low.

The insurance industry has made some changes in the wake of COVID-19, and as patients needs evolve with time and medical recommendations, Aflac CEO Dan Amos said.

Moderna says its updated coronavirus vaccine offers a “strong" response to a new COVID-19 variant that is being monitored by the CDC and WHO.

News that the Biden administration is planning to push for Americans to get the updated COVID vaccines this fall caused several vaccine manufacturers' stock prices to rise Monday.

Moderna CEO Stéphane Bancel explains how technology from a promising new melanoma vaccine with Merck could help treat and defeat other diseases like lung, prostate and breast cancers.

COVID-19 vaccine maker Moderna's shares fell on Thursday following the release of the company's third-quarter earnings, which showed a decline in revenue.

With COVID cases on the rise in China, the government has approved Livzon Pharmaceutical's COVID-19 vaccine as a booster, in hopes of having as many people boosted as possible.

The Centers for Disease Control and Prevention gave final approval to updated COVID-19 vaccines targeting the dominant omicron variant on Thursday.

According to the White House's COVID-19 response coordinator Dr. Ashish Jha, the U.S has begun distributing COVID-19 vaccines for children as young as six months.

Pfizer and Moderna's vaccines for children as young as 6 months old could be available next week after an FDA advisory panel recommended them on Wednesday.